The Demise Of A Once Promising Pancreatic Cancer Drug Is All Too Common

Companies as small as Nivien or as large as Pfizer find the chemical tools and run the experiments that prove or disprove medical hypotheses.

Source: Forbes.com Healthcare News - January 15, 2019 Category: Pharmaceuticals Authors: John LaMattina, Contributor Tags: NYSE:PFE NYSE:MRK NYSE:LLY NYSE:NVS Source Type: news